Navigation Links
Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
Date:5/12/2008

MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) is increasing the Company's commercial focus with the appointment of David C. Tantillo as Senior Director, Marketing and Sales, a newly created position. Beginning today, Mr. Tantillo will be responsible for planning and implementing commercialization of the Company's haptoglobin diagnostic test. Synvista expects commercial launch of this product in mid- 2009.

Mr. Tantillo brings to Synvista nearly 20 years of broad-based industry experience, having successfully directed programs in diabetes, oncology, infectious disease, pain, inflammation and other therapeutic areas. His work has included diagnostics, pharmaceuticals, and medical devices, as well as health and disease management services and managed care initiatives. His experience also includes a combination diagnostic, drug and drug delivery device. He has overseen marketing programs for commercial products, as well as those in early- and late-stage clinical development. He also has been involved in several marketing and development partnerships, as well as with new business acquisitions.

"David has a strong track record of success, and we are delighted to welcome him to the Synvista team to initiate our first commercialization program for our haptoglobin diagnostic," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista Therapeutics. "We look forward to working with David to usher in a new era for Synvista, relying heavily on his extensive experience in bringing products to market, specifically with testing products and in the diabetes arena."

Prior to joining Synvista, Mr. Tantillo was Director Strategic Marketing at Alpharma Pharmaceuticals. Fro
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
2. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Synvista Therapeutics to be Featured on Wallst.net
5. Synvista Therapeutics to Present at the BIO InvestorForum 2007
6. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
7. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
8. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
9. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
10. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
11. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014  ( www.competitivehealth.com ) — Competitive Health ... bill review and advocacy service, has signed an agreement ... Savings discount health services marketplace. 63% of ... than they expected to pay. As part of an ... WellCard Savings is pleased to offer medical bill review ...
(Date:12/19/2014)... 2014 Charm Sciences is pleased to ... Detection of Aflatoxin M1 in raw commingled milk is ... party validation. The peer reviewed report of the validation ... for Agricultural and Fisheries Research (ILVO-T&V) has been published ... B1, the most toxic aflatoxin and a known carcinogen, ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for ... Excellence in the Neurosciences (CEN), and professor of pharmacology ... as a member of the prestigious Dana Alliance for ... Maine to receive this honor. , The Dana ... the Dana Foundation. Its mission is to advance ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... 26 Shasta Regional Medical Center,has earned the ... demonstrating,compliance with the Joint Commission,s national standards for ... has been awarded its full,accreditation. , ... an unannounced, initial on-site evaluation,of Shasta Regional Medical ...
... ORANGE COUNTY, Calif., Nov. 25 Beckman Coulter, Inc. (NYSE: ... of products that simplify, automate, and innovate complex biomedical testing, ... Strategy and Business Development, will present at the following conferences: ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) , , , ...
... (Nasdaq: SIAL ),announced today it has entered ... This collaboration is expected to support,the development and ... a planned launch of many of these products in ... tools for regenerative medicine,are expected to consist of serum-free ...
Cached Biology Technology:Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 2Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 3Beckman Coulter to Present at Upcoming Healthcare Conferences 2Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine 2Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine 3
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... LANSING, Mich. Most organisms would die in the ... simple algae call it home, and their secrets to ... Garavito, Michigan State University professor of biochemistry and molecular ... how primitive red algae use horizontal gene transfer, in ...
... (Bronx, NY) Researchers at Albert Einstein College ... $12 million grant from the National Institutes of Health (NIH) ... in women. "As we move into the fourth decade ... impact on women, particularly in sub-Sahara Africa," said principal investigator ...
... the Wildlife Conservation Society Canada (WCS Canada) creates a ... in the Southern Canadian Rockies to the future impacts ... "safe passages and safe havens" were informed in ... westslope cutthroat trout, grizzly bears, wolverines, mountain goats and ...
Cached Biology News:Home toxic home 2Einstein receives $12 million grant to develop device for preventing HIV infection 2Einstein receives $12 million grant to develop device for preventing HIV infection 3'Climate-smart strategies' proposed for spectacular US-Canadian landscape 2
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Biology Products: